PannonPharma
Generated 5/9/2026
Executive Summary
PannonPharma is a Hungarian pharmaceutical company founded in 2010, headquartered in Budapest, with its manufacturing facility in Pécsvárad. The company specializes in the development, manufacturing, and sale of generic drugs, over-the-counter (OTC) medicines, and dietary supplements. Its product portfolio covers treatments for respiratory conditions, skin infections, allergies, and general wellness, combining modern manufacturing techniques with a commitment to traditional quality. As a private entity, PannonPharma operates primarily in the Central and Eastern European generic drug market, a segment characterized by steady demand due to cost-conscious healthcare systems and aging populations. The company's focus on affordable generics and OTC products positions it to benefit from ongoing patent expirations and the shift towards self-medication. However, its private status and lack of disclosed financials or pipeline visibility limit external assessment of its growth trajectory and competitive standing.
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)